In order to tailor the site to your needs, please click the button that relates best to you.
So long as you have cookies enabled you will only need to do this once. However, you can change your selection at any time using the dropdown navigation option above the CESPHN logo, top left.
This post is not the latest immunisation update and therefore may contain information or advice that is out of date. Please see our most recent update here.
First case of measles in NSW in over 2 years confirmed in an adult resident of South Eastern Sydney LHD. Infection was acquired overseas. The person was infectious in the community for several days, with known exposures at:
St Andrew’s Catholic Church Malabar on September 4
Maroubra Road Physiotherapy on September 5
UNSW on September 6
Pacific Square Malabar on 7 September in the morning
GPs are advised to be alert for cases presenting – isolate patients with fever and rash in a separate room on arrival and notify the PHU about all suspected cases (do not wait for test results). Collect a nose and throat swab and a first pass urine sample for measles PCR, and blood for measles serology (IgM and IgG). Mark tests as urgent (PHU can assist with expediting).
From 10 October 2022, Moderna Bivalent will be included in the COVID-19 Vaccination Program for boosters in people aged 18 years, as per ATAGI advice.
Clinicians will be required to complete the relevant training modules prior to administering the Moderna bivalent vaccine. All sites currently participating in the COVID-19 Vaccine Program will be onboarded for Moderna bivalent 18+ blue/green in tranches. Your PHN will advise you which tranche you will be onboarded in. All primary care sites will receive an ongoing allocation of 100 doses of Moderna bivalent 18+ blue/green.
ATAGI has provided recommendations following the TGA provisional registration for Moderna Spikevax Bivalent (Original/Omicron BA.1) vaccine for use as a booster dose in people aged 18 years and older:
The Moderna bivalent vaccine can be used as an alternative vaccine for any booster dose in people aged 18 years or older, according to the current ATAGI recommendations for booster doses.
ATAGI have made no changes to the current booster recommendations and is not advising any extra booster doses beyond the second booster dose (fourth dose) in selected populations.
The booster dose of COVID-19 vaccine should be given at least 3 months after the most recent COVID-19 vaccine dose or previous COVID-19 infection
Co-administration of Moderna bivalent vaccine with other non-COVID vaccines is acceptable, as per current ATAGI clinical guidance.
The bivalent Moderna vaccine is not recommended for primary course of vaccination (first two doses in most people or first three doses in severely immunocompromised people).
ATAGI does not currently recommend use of the Moderna bivalent vaccine as a booster in anyone under 18 years as it is not registered for this age group.
CESPHN is inviting registered nurses to apply for a scholarship to become a qualified Authorised Nurse Immuniser in NSW. CESPHN are offering successful applicants 100% scholarship to the Understanding Vaccines and the National Immunisation Program.
For more information about the scholarship and to apply, see CESPHN Immunisation website. Applications close 30 September 2022.
Webinars
COVID-19 response update
About: primary care update on the COVID-19 response and the vaccine rollout – key updates and Q&A
Thursday 2 September 2022 at 12:00pm to 12:30pm (AEST) – **note new time
About: latest information regarding the Monkeypox virus including vaccination, identification, treatment, and case management.
Speaker: Presented by Dr Kasha Singh, Infectious Diseases physician at the Royal Melbourne Hospital and clinical researcher based at The P eter Doherty Institute of Infection and Immunity in Melbourne, Australia.
Register:Click here to register for event on Tuesday 20 September 2022, 12:30 pm – 1:00 pm
Target audience: All primary health professionals
Adolescent Vaccination
About: Listen to adolescent health experts discuss the key role of General Practice in improving uptake of recommended adolescent vaccinations, adolescent preventative health topics , and communication with young patients
Register:RSVP here for Thursday 15 September at 1pm
CPD: the 1 hour webinar is RACGP accredited attracting 2 CPD points
About: A virtual showcase of inspiring presentations from Australian and international experts to commemorate the moments that have shaped the immunisation landscape over the past 25 years, with a look towards the future.
Welcome to our new website! As you may have noticed, our website looks different. Central and Eastern Sydney PHN have moved to a new site and although much has remained the same, we have introduced some new functions. These include: Updated navigation When you land on our new website, you…
Immunisation weekly update – 8 February 2023 HPV vaccination now single dose on NIP Changes from 6 February 2023 to human papillomavirus vaccination (Gardasil®9) dose schedule under the National Immunisation Program: Routine schedule for people aged 12 to 13 years will change to a single dose (previously a 2 dose…
Sydney World Pride 2023 – General Practice Support CESPHN is a proud supporter of the Sydney WorldPride 2023 that is occurring from 17 February to 5 March 2023. To assist people to get the right care and avoid unnecessary presentations to emergency departments, we are encouraging general practices to review…
COVID-19 weekly update – 08 JANUARY 2023 ATAGI 2023 Booster Advice The Australian Technical Advisory Group on Immunisation (ATAGI) have updated their recommendations on the use of booster doses of COVID-19 vaccine in 2023. ATAGI recommends a 2023 COVID-19 vaccine booster dose for adults in the following groups, if their…
MEDIA RELEASE: Canterbury Head to Health service opens doors to offer free, immediate mental health support. Canterbury Head to Health opened its doors in late January, offering free and immediate support for anyone in Canterbury and the surrounding regions experiencing distress or mental health concerns.Trained professionals are providing short to…
CESPHN Vax at Home service The CESPHN Vax at Home Service is for those people who are housebound and not able to leave their house to receive a COVID-19 vaccination or booster. The service will accept referrals for people 16 years and over. Referrals will be accepted from GPs and…
IAR-DST Training resumes today The implementation of the Initial Assessment and Referral Decision Support Tool (IAR-DST) training is gaining momentum both within CESPHN and nationally. National GP training numbers are closing in on 300 and over 50 of these have been trained by CESPHN. This year we are excited to…